{ "ProductData": { "ID": "3.7.9.16.1.2", "ProductType": "Others", "BrandName": "MAB<H-S-Amy>M-Tu66C7 IgG", "ProductNameAddition": "lyophilizate", "RegulatoryDisclaimer1": "For further processing only.", "DisclaimerGroup1": "", "RegulatoryDisclaimer2": null, "DisclaimerGroup2": null, "RegulatoryDisclaimer3": null, "SampleType": [ ], "LicenseDisclaimers": [ ], "RelatedLinks": "", "Clone": "", "ControlTissue": [ "" ], "ISOtypes": "", "Species": [ "" ], "StainLocalization": [ "" ], "ProductNameGlobal": "MAB H-S-Amy M-Tu66C7 IgG" }, "ProductImageDetails": { "ImagePath": "https://pim-media.roche.com/Images/CB_IMAGE_.png", "ImageType": "Image main" }, "Product2Taxonomy": { "Product2TaxonomyReferences": [ { "StructureSystemIdentifier": "OWP_Product_Types", "StructureSystemName": "Product Types", "NodeID": "70-058-00", "StructureNodeStatus": "valid", "NodeName": "Antibodies" }, { "StructureSystemIdentifier": "OWP_Organization", "StructureSystemName": "Organization", "NodeID": "01-01-01-07-00", "StructureNodeStatus": "valid", "NodeName": "CustomBiotech and LifeScience" }, { "StructureSystemIdentifier": "Product_Grouping", "StructureSystemName": "Product Grouping", "NodeID": "02-0011", "StructureNodeStatus": "valid", "NodeName": "Clinical Chemistry Raw Materials" }, { "StructureSystemIdentifier": "Applications", "StructureSystemName": "Applications", "NodeID": "06-00-00", "StructureNodeStatus": "valid", "NodeName": "Enzyme Testing" }, { "StructureSystemIdentifier": "Product_Solutions", "StructureSystemName": "Product Solutions", "NodeID": "520", "StructureNodeStatus": "valid", "NodeName": "CustomBiotech" }, { "StructureSystemIdentifier": "Lab_Type", "StructureSystemName": "Lab Types", "NodeID": "180-00", "StructureNodeStatus": "invalid", "NodeName": "" }, { "StructureSystemIdentifier": "OWP_Techniques", "StructureSystemName": "Techniques", "NodeID": "999-00", "StructureNodeStatus": "invalid", "NodeName": "" }, { "StructureSystemIdentifier": "Disease_Areas", "StructureSystemName": "Disease Areas", "NodeID": "99-00-00", "StructureNodeStatus": "invalid", "NodeName": "" }, { "StructureSystemIdentifier": "Pathogens", "StructureSystemName": "Pathogens", "NodeID": "99-00-00", "StructureNodeStatus": "invalid", "NodeName": "" }, { "StructureSystemIdentifier": "OWP_Family", "StructureSystemName": "Product Families", "NodeID": "999", "StructureNodeStatus": "invalid", "NodeName": "" }, { "StructureSystemIdentifier": "Health_Topics", "StructureSystemName": "Health Topics", "NodeID": "99-00-00", "StructureNodeStatus": "invalid", "NodeName": "" } ] }, "Product2Materials": { "P2MaterialReferences": [ { "MaterialNum": "11543601103", "MaterialDescription": "MAKM-Tu66C7-IgG(BR)SQ", "RegisteredProductName": "MABM-Tu66C7 IgG", "GTIN": "", "ProductCategoryText": "Reagents, kits", "OldMaterialNumber": "", "PackSizePIM360": "custom fill", "PackSizeDescPIM360": "Not Available", "MaterialAnnotation": "CustomBiotech product. Please contact your local representative.", "ReadyForUse": "", "OrderInformation": "Will be supplied as \"MAK<H-S-Amy>M-Tu66C7-IgG(BR)SQ\". Unit of measure is \"g active ingredient\"." } ] }, "Product2Products": { "Product2ProductReference": [ ] }, "ProductSpec": [ { "ProductSpecVariant": { "Chapters": [ { "Name": "CB - Order Information", "Value": "Will be supplied as \"MAK<H-S-Amy>M-Tu66C7-IgG(BR)SQ\". Unit of measure is \"g active ingredient\".", "Language": "en", "Country": "XG", "Code": "CB - Order Information" }, { "Name": "Applications", "Value": "The combination of MAB<H-S-Amy>Tu88E8 and MAB<H-S-Amy>Tu66C7 inhibits the human salivary α-amylase ≥97% while maintaining the activity of the pancreatic h-α-amylase.", "Language": "en", "Country": "XG", "Code": "Applications" }, { "Name": "Product Description", "Value": "Immunogen: Human salivary amylase
Spleen donor: Mouse Balb/c
Antibody class: IgG1, kappa
Clone: Tu66C7
Cross reactivity to h-pancreas α-amylase: ≤1 U/gW", "Language": "en", "Country": "XG", "Code": "Product Description" }, { "Name": "Positioning", "Value": "For measurement of acute pancreatitis (pancreatic α-amylase) in human serum and urine selective blocking of salivary α-amylase isoenzyme is achieved in the presence of the pancreatic h-α-amylase.
Qualified for the cobas® platforms.", "Language": "en", "Country": "XG", "Code": "Positioning" }, { "Name": "Properties", "Value": "MAB<H-S-Amy>M-Tu66C7 IgG fraction is purified by chromatography and lyophilized from a solution containing protein (≥20 mg/mL), potassium-phosphate buffer and NaCl. No preservatives are added.", "Language": "en", "Country": "XG", "Code": "Properties" }, { "Name": "Specification", "Value": "Appearance: White lyophilizate
Solubility: Clear colorless solution in NaCl, 0.9% (c=10 mg/mL)
Protein (Biuret): ≥0.7 mg/mg lyophilizate
Purity (HPLC / Mono Q): ≥90 area%
Function testing (synergetic effects at +37°C):
h salivary amylase + MAB : ≤3% amylase activity
h pancreas amylase + MAB <S-AMY>: ≥98% amylase activity
Stability: At -15 to -25°C within specification range for 24 months. Avoid repeated freezing and thawing.", "Language": "en", "Country": "XG", "Code": "Specification" } ] } } ] }

MAB<H-S-Amy>M-Tu66C7 IgG

lyophilizate

logo

Ordering Information

Technical documents

for certificates, method sheets (instructions for use), safety data sheets and software downloads
error errorMessage
Sorry, we couldn't find the content you are looking for
Please try again later